IDP Pharma´s CEO will participate as an expert guest at the European Drug Discovery Innovation & Outsourcing program conference that

IDP Pharma has entered into a licensed option with a USA based Biotech for IDP-602, a first in class drug

IDP Pharma, in collaboration with Carlos III Research Institute (ISCIII) and Hospital 12 de Octubre in Madrid, has published a

IDP Pharma will present at the Annual Meeting of the American Association for Cancer Research (June 22-24) its first in

Bio€quity 2019, the most important biopharmaceutical investor conference in Europe, will take place in Barcelona for the first time on